LOC100507002: A Drug Target / Disease Biomarker (G100507002)
LOC100507002: A Drug Target / Disease Biomarker
LOC100507002 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. LOC100507002 is unique due to its ability to interact with other proteins, particularly the protein TPM1, which is also known as calbindin.
The study of LOC100507002 has identified several potential drug targets. For one, LOC100507002 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, LOC100507002 has been shown to interact with several other proteins, including the protein FBN1, which is involved in the formation of blood clots. This suggests that LOC100507002 may be a useful biomarker for monitoring the effectiveness of anti-clotting medications.
Another potential drug target for LOC100507002 is its role in the regulation of cell division. LOC100507002 has been shown to play a role in the control of cell proliferation and has been implicated in the development of cancer. Additionally, LOC100507002 has been shown to interact with the protein p21, which is a known regulator of cell division. This suggests that LOC100507002 may be a useful target for drugs that are designed to inhibit cell division in cancer cells.
LOC100507002 has also been studied for its potential role in the regulation of pain perception. LOC100507002 has been shown to interact with the protein TrkB, which is involved in the transmission of pain signals from the body to the brain. This suggests that LOC100507002 may be a useful target for drugs that are designed to inhibit pain perception.
In conclusion, LOC100507002 is a protein that has been studied for its potential role in the development and progression of various diseases. Based on the results of these studies, LOC100507002 is a promising drug target for the treatment of a wide range of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, LOC100507002 may also be a useful biomarker for monitoring the effectiveness of anti-clotting medications and for identifying new targets for pain medications.
Protein Name: Uncharacterized LOC100507002
More Common Targets
LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531 | LOC101927548 | LOC101927550 | LOC101927571 | LOC101927588 | LOC101927598 | LOC101927605 | LOC101927609 | LOC101927627 | LOC101927636 | LOC101927668 | LOC101927712 | LOC101927727 | LOC101927741 | LOC101927745 | LOC101927770 | LOC101927787 | LOC101927825 | LOC101927827 | LOC101927834 | LOC101927840
